Cognition Therapeutics

CGTX

0.68708.12% ( +0.0516 )

Closed: Nov 6, 16:00:01 (EDT)

Current ValuationThe current P/E ratio is -3.60, within the reasonable range, cheaper than 73.52% of the time in the past 5 years, and the industry ranks 156/257, the industry Median -1.08.

-3.6xP/E

Stock price$0.64Earnings per share$-0.18

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

03774111148

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
BAYRYUSBayer	-36.69x	--	$60.99B
BAYZFUSBayer Aktiengesellschaft	-36.85x	--	$61.25B
VTRSUSViatris	-35.85x	107.68%	$21.79B
ELANUSElanco Animal Health	-59.45x	130.52%	$11.83B
ABVXUSAbivax SA	-15.78x	22.99%	$7.34B
CURLFUSCuraleaf Holdings, Inc.	-137.57x	--	$7.23B
AXSMUSAxsome Therap	-43.41x	31.92%	$6.83B
VREOFUSVIREO GROWTH INC	-94.54x	--	$6.35B
BLTEUSBelite Bio	-56.33x	29.87%	$5.77B
MANEUSVeraDermics	-51.52x	97.44%	$5.37B
DFTXUSDefinium Therapeutics	-11.53x	54.55%	$4.08B
AMLXUSAmylyx Pharmaceuticals	-21.24x	1.76%	$3.47B
ELVNUSEnliven Therapeutics	-30.98x	1.64%	$3.28B
BHCUSBausch Health	-3.54x	511.90%	$2.98B
TARSUSTarsus Pharmaceuticals	-4.22x	853.77%	$2.96B
RGCUSRegencell Bioscience	-223.14x	--	$2.61B
XERSUSXeris Biopharma	-367.11x	--	$2.38B
MBXUSMBX Biosciences	-22.38x	31.12%	$2.33B
PHVSUSPharvaris BV	-11.53x	10.43%	$2.28B
SEPNUSSepterna	-91.19x	22.70%	$2.21B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.